Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
D. James Bidzos, Executive Chairman, President, and CEO of Verisign Inc (NASDAQ:VRSN), sold 8,888 shares of common stock between October 14 and October 16, 2025, according to a Form 4 filing with the Securities and Exchange Commission. According to InvestingPro data, Verisign maintains impressive gross profit margins of 87.9% and currently has a market capitalization of $24.3 billion.
The sales, which totaled $2,379,578, occurred at weighted average prices ranging from $259.9785 to $266.867 per share. Based on InvestingPro’s Fair Value analysis, the stock appears to be trading near its fair value, with the current price of $259.79 sitting well above its 52-week low of $175.62.
Specifically, on October 14, Bidzos sold 550 shares in multiple transactions at prices ranging from $263.51 to $264.34, 2,192 shares at prices between $264.54 and $265.50, 1,258 shares at prices ranging from $265.62 to $266.57 and 1,000 shares at prices ranging from $266.70 to $266.99. On October 15, Bidzos sold 600 shares at prices ranging from $262.27 to $262.70, 712 shares at prices between $263.71 and $264.47, 488 shares at prices ranging from $264.78 to $265.68 and 200 shares at prices ranging from $265.78 to $266.15. On October 16, Bidzos sold 922 shares in multiple transactions at prices ranging from $259.59 to $260.50, 200 shares at prices between $260.82 and $261.74, 200 shares at prices ranging from $261.99 to $262.92, 500 shares at prices ranging from $263.77 to $264.09 and 178 shares at prices ranging from $264.97 to $264.98.
Following these transactions, Bidzos directly owns 467,438.7009 shares of Verisign Inc . The company maintains a GOOD financial health score according to InvestingPro, which offers comprehensive analysis and additional insights through its Pro Research Report, available for over 1,400 US stocks.
In other recent news, VeriSign Inc. has been at the center of significant developments. The company announced that Berkshire Hathaway plans to reduce its stake in VeriSign by selling 4.3 million shares at $285 each, amounting to a $1.23 billion stock offering. This move is intended to lower Berkshire Hathaway’s ownership below the 10% threshold to avoid additional regulatory obligations. The offering is managed by J.P. Morgan Securities LLC, and all proceeds will go to the selling stockholders, with VeriSign not receiving any proceeds from the transaction. Additionally, VeriSign has expanded its board of directors by appointing Matthew J. Desch, currently CEO of Iridium Communications Inc., increasing the board’s size from seven to eight members. These developments reflect ongoing strategic adjustments within the company and its shareholder base.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.